Thoughts on the research of African swine fever live-attenuated vaccines.
Vaccine
; 42(25): 126052, 2024 Nov 14.
Article
in En
| MEDLINE
| ID: mdl-38906762
ABSTRACT
African swine fever (ASF) is a contagious and fatal disease caused by the African swine fever virus (ASFV), which can infect pigs of all breeds and ages. Most infected pigs have poor prognosis, leading to substantial economic losses for the global pig industry. Therefore, it is imperative to develop a safe and efficient commercial vaccine against ASF. The development of ASF vaccine can be traced back to 1960. However, because of its large genome, numerous encoded proteins, and complex virus particle structure, currently, no effective commercial vaccine is available. Several strategies have been applied in vaccine design, some of which are potential candidates for vaccine development. This review provides a comprehensive analysis on the safety and effectiveness, suboptimal immunization effects at high doses, absence of standardized evaluation criteria, notable variations among strains of the same genotype, and the substantial impact of animal health on the protective efficacy against viral challenge. All the information will be helpful to the ASF vaccine development.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccines, Attenuated
/
Viral Vaccines
/
African Swine Fever
/
African Swine Fever Virus
Limits:
Animals
Language:
En
Journal:
Vaccine
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: